This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Katie Landes
Executive Director, Head of Patient Advocacy and Government Affairs at Stealth Biotherapeutics
Speaker

Profile

Katie Landes is the Senior Director, Strategy & Execution at KPM Group DC, a concierge public + government affairs firm that champions the unique needs of emerging rare disease and brain health biotechnology companies who are on the frontlines of scientific innovation, research and development. In this role, Katie supports rare disease biotech companies with the development + execution of their government affairs strategies. She currently advises nearly a dozen biotech companies, including the Rare Disease Company Coalition. 

Agenda Sessions

  • Maximizing Patient Advocacy Partnerships – Creating Strategic Value Through Collaborative Engagement

    8:15am